Professional Issues in Pharmacotherapy for Psychologists

Professional Psychology: Research and Practice

Volumn 35, Issue 2, 2004, Pages 158-163

  McGrath, Robert E ^a   Sammons, Morgan T ^b   Brown, Anita ^c,g   Wiggins, Jack G ^d   Levant, Ronald F ^e   Stock, Wendy ^f  

^a FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^b Bureau of Medicine and Surgery   (United States)

^c HAMPTON UNIVERSITY   (United States)

^d MISSOURI INSTITUTE OF MENTAL HEALTH   (United States)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

^f ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^g Fairleigh Dickinson University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842853954     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.35.2.158     Document Type: Article

References (36)

1. American Psychological Association. (1996). Recommended postdoctoral training in psychopharmacology for prescription privileges. Washington DC: Author.
2. Bartels, S. J., Dums, A. R., Oxman, T. E., Schneider, L. S., Areán, P. A., Alexopoulos, G. S., & Jeste, D. V. (2002). Evidence-based practices in geriatric mental health care. Psychiatric Services, 53, 1419-1431.
3. Bodenheimer, T. (2000). Uneasy alliance - Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1544.
4. Bray, J. H., Enright, M. F., & Rogers, J. (1997). Collaboration with primary care physicians. In J. A. Morris (Ed.), Practicing psychology in rural settings: Hospital privileges and collaborative care (pp. 55-65). Washington, DC: American Psychological Association.
5. Casacalenda, N., Perry, J. C., & Looper, K. (2002). Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions. American Journal of Psychiatry, 159, 1354-1360.
6. Cho, M., Shohara, R., Schissel, A., & Rennie, D. (2000). Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association, 284, 2203-2208.
7. Choudhry, N. K., Stelfox, H. T., & Detsky, A. S. (2002). Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Journal of the American Medical Association, 287, 612-617.
8. Davidoff, F., DeAngelis, C. D., Drazen, J. M., Hoey, J., Hojgaard, L., Horton, R., et al. (2001). Sponsorship, authorship, and accountability. Journal of the American Medical Association, 286, 1232-1234.
9. DeNelsky, G. Y. (1996). The case against prescription privileges for psychologists. American Psychologist, 51, 207-211.
10. Engel, G. L. (1977, April 8). The need for a new medical model: A challenge for biomedicine. Science, 196, 129-136.
11. Gabbard, G. O., & Kay, J. (2001). The fate of integrated treatment: Whatever happened to the biopsychosocial psychiatrist? American Journal of Psychiatry, 158, 1956-1963.
12. Goldman, W., McCulloch, J., Cuffel, B., Zarin, D. A., Suarez, A., & Burns, B. J. (1998). Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatric Services, 49, 477-482.
13. Hayes, S., & Heiby, E. (1996). Psychology's drug problem: Do we need a fix or should we just say no? American Psychologist, 51, 198-206.
14. Heiby, E. M. (2002). Concluding remarks on the debate about prescription privileges for psychologists. Journal of Clinical Psychology, 58, 709-722.
15. Hines, D. (1997). Arguments for prescription privileges for psychologists. American Psychologist, 52, 270-271.
16. Khan, A., Leventhal, R. M., & Khan, S. R. (2002). Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. Journal of Clinical Psychopharmacology, 22, 40-45.
17. Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002, July 15). The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration [Article 23]. Prevention & Treatment, 5. Retrieved September 25, 2002, from http://journals.apa.org/ prevention/volume5/pre0050023a.html
18. Lawton-Smith, S. (2002). Patient adherence with antidepressant treatment. British Journal of Psychiatry, 181, 78.
19. Levant, R. F., & Sammons, M. T. (2002). Of Cassandras, canards, and the dog in the night-time. Journal of Clinical Psychology, 9, 259-263.
20. Luhrmann, T. M. (2000). Of two minds: The growing disorder in American psychiatry. New York: Knopf.
21. Mojtabai, R., Lavelle, J., Gibson, P. J., Sohler, N. L., Craig, T. J., Carlson, G. A., & Bromet, E. J. (2002). Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatric Services, 53, 337-339.
22. Moncrieff, L. (2001). Are antidepressants overrated? A review of methodological problems in antidepressant trials. Journal of Nervous and Mental Disease, 189, 288-295.
23. National Depressive and Manic Depressive Association. (2000). Beyond diagnosis: Depression and treatment - A call to action to the primary care community and people with depression. Chicago: Author.
24. Norfleet, M. A. (2002). Responding to society's needs: Prescription privileges for psychologists. Journal of Clinical Psychology, 58, 599-610.
25. Pampallona, S., Bollini, P., & Tibaldi, G. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104-109.
26. Pincus, H. A., Zarin, D. A., Tanielian, T. L., Johnson, J. L., West, J. C., Pettit, A. R., et al. (1999). Psychiatric patients and treatments in 1997: Findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry, 56, 441-449.
27. Robiner, W. N., Bearman, D. L., Berman, M., Grove, W. M., Colon, E., Armstrong, J., & Mareck, S. (2002). Prescriptive authority for psychologists: A looming health hazard? Clinical Psychology: Science and Practice, 9, 231-248.
28. Ross, J. S., Lurie, P., & Wolfe, S. M. (2000, July 19). Medical education services suppliers: A threat to physician education. Retrieved July 24, 2002, from http://www.citizen.org/publications/release.cfm?ID=7142#122
29. Sammons, M. T. (2001). Combined treatments for mental disorders: Clinical dilemmas. In M. T. Sammons & N. B. Schmidt (Eds.), Combined treatments for mental disorders: A guide to psychological and pharmacological interventions (pp. 11-32). Washington, DC: American Psychological Association.
30. Satcher, D. (1999). Mental health: A report of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services.
31. Shakow, D. (1965). Seventeen years later: Clinical psychology in the light of the 1947 Committee on Training in Clinical Psychology report. American Psychologist, 20, 353-362.
32. Sward, K. (1950). Are the psychologists afraid of therapy? American Psychologist, 5, 50-54.
33. Tonks, A. (2003). Extracts from "Best Treatments": Treating generalised anxiety disorder. British Medical Journal, 326, 700-701.
34. VandenBos, G. R., & Williams, S. (2000). Is psychologists' involvement in the prescribing of psychotropic medication really a new activity? Professional Psychology: Research and Practice, 31, 615-618.
35. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283, 373-380.
36. Wiggins, J. G., & Cummings, N. A. (1998). National study of the experience of psychologists with psychotropic medication and psychotherapy. Professional Psychology: Research and Practice, 29, 549-552.